The day's most important news and information. A Fourth Estate® Service

Thursday, May 13, 2021
Shares of Gilead Sciences jumped 6 percent on Friday morning after United States authorities approved its antiviral drug remdesivir as the treatment for the COVID-19 virus in the country.
This article has been archived. Log in or Subscribe to access archived content.